Asset 1

Enzyme Induction Services

Cytochrome P450 and UGT induction studies to predict drug-drug interaction.

Gentest® Research Services offers in vitro cytochrome P450 (CYP) and UGT enzyme induction assays, predicting drug-drug interaction potential.

We have 20+ years of expertise in regulatory compliant ADME services. We provide in-process communication, IND submission-ready reports, and reliable results using Gentest® products and services.

Testing for Comprehensive Drug Metabolizing Enzymes

Robust Dynamic Range and Customizable Assays

Robust Dynamic Range to Assess Induction Response

Flexibility to use multiple inducers or assays for the same enzyme with robust analytical sensitivity. Mean and standard deviation of fold induction of enzyme activity in 3 donors after treatment of 50 μM omeprazole (OME), 20 μM ß-naphthoflavone (BNF), 1 mM phenobarbital (PB), or 10 μM rifampicin (RIF). Enzyme activities measured were phenacetin O-deethylase, S-mephenytoin N-demethylase, bupropion hydroxylase, amodiaquine N-deethylase, diclofenac 4’-hydroxylase, S-mephenytoin 4’-hydroxylase, and testosterone 6ß-hydroxylase.

Consistent, Reproducible Results

Reproducible Induction Response in Gentest® Inducible-qualified Human Cryo-hepatocytes

Omeprazole-induced CYP1A2 catalytic activity in Gentest® Inducible-qualified human cryo-hepatocytes on 7 independent days

Highly reproducible, robust data. Phenacetin O-deethylase activity in a single donor (lot 246) of Gentest® Inducible-qualified human cryopreserved hepatocytes in 7 independent experiments conducted over the span of 18 weeks. Cells were treated with 50 μM omeprazole (OME) for 2 days prior to determination of enzyme activity. The amount of acet- aminophen metabolite formation was determined by incubating cells with 100 μM phenacetin for 30 minutes.

Featured Publications

Zhang JG, et al (2014). Evaluation of calibration curve-based approaches to predict clinical inducers and non-inducers of CYP3A4 with plated human hepatocytes. Drug Metab. Dispos. 42:1379-1391.

Wong, S.G. et al (2021). Considerations from the innovation and quality induction working group in response to drug-drug interaction guidance from regulatory agencies: Guidelines on model fitting and recommendations on time course for in vitro cytochrome P450 induction studies including impact on drug interaction risk assessment. Drug Metab. Dispos. 49:94-110.

Contact Us Today

Quick Links


Development and Clinical
Trial Solutions